The Onco Life Podcast
Welcome to The Onco Life Podcast, your trusted source for cancer care insights, treatment updates, and patient-centered education. Hosted by the team at Onco Life Centre in Kuala Lumpur, Malaysia, this podcast is designed to guide patients, caregivers, and listeners through every stage of the cancer journey.
Each episode features expert advice from our oncologists, wellness tips, treatment innovations, and answers to the most common questions about cancer types, therapies, and recovery.
🎧 Empowering you with knowledge, support, and compassionate care—every step of the way.
📍 Kuala Lumpur, Malaysia
🌐 Learn more at oncolifecentre.com
The Onco Life Podcast
Breakthrough in Lung Cancer Treatment: Lurbinectedin and Atezolizumab Combo Extends Survival in ES-SCLC Patients
A new FDA-approved combination of lurbinectedin and atezolizumab is changing the outlook for patients with extensive-stage small cell lung cancer (ES-SCLC). This first-line maintenance therapy offers a major step forward in extending survival and disease control after initial treatment.
In this episode, you’ll learn:
• How the lurbinectedin + atezolizumab combo improves survival and progression-free outcomes
• Key findings from the IMforte Phase 3 clinical trial
• What makes this treatment a new first-line maintenance option for ES-SCLC
• Important safety and monitoring considerations for patients
• Eligibility criteria and what it means for those in Malaysia
• Why oncologists view this as a “practice-changing” advancement
• How Onco Life Centre supports patients exploring new treatment options
This episode highlights a breakthrough that brings renewed hope to patients and families facing one of the most aggressive types of lung cancer.
Blog Link: Breakthrough in Lung Cancer: Lurbinectedin Combo Offers New Hope for ES-SCLC Patients
Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.
Author: Dr. CHRISTINA NG VAN TZE
📍 Visit us at oncolifecentre.com
📞 Call: +603-2242-2620
📧 Book a consultation or ask a question — we're here to support your journey.